nicardipine has been researched along with Malignant Hypertension in 3 studies
Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We investigated the potential role of increased plasma adrenomedullin and brain natriuretic peptide (BNP) levels in a patient with malignant hypertension." | 7.69 | Antihypertensive therapy reduces increased plasma levels of adrenomedullin and brain natriuretic peptide concomitant with regression of left ventricular hypertrophy in a patient with malignant hypertension. ( Ishikawa, K; Kangawa, K; Kawano, Y; Kitamura, K; Matsuo, H; Matsuoka, H; Nishikimi, T; Omae, T; Saito, Y; Yoshihara, F, 1996) |
| "We investigated the potential role of increased plasma adrenomedullin and brain natriuretic peptide (BNP) levels in a patient with malignant hypertension." | 3.69 | Antihypertensive therapy reduces increased plasma levels of adrenomedullin and brain natriuretic peptide concomitant with regression of left ventricular hypertrophy in a patient with malignant hypertension. ( Ishikawa, K; Kangawa, K; Kawano, Y; Kitamura, K; Matsuo, H; Matsuoka, H; Nishikimi, T; Omae, T; Saito, Y; Yoshihara, F, 1996) |
| " Nicardipine appeared to be safe and effective in controlling hypertension in these patients." | 1.31 | Nicardipine is a safe and effective agent in pediatric hypertensive emergencies. ( Sakarcan, A; Tenney, F, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Patel, A | 2 |
| Patel, H | 1 |
| Tenney, F | 1 |
| Sakarcan, A | 1 |
| Nishikimi, T | 1 |
| Matsuoka, H | 1 |
| Ishikawa, K | 1 |
| Yoshihara, F | 1 |
| Kawano, Y | 1 |
| Kitamura, K | 1 |
| Saito, Y | 1 |
| Kangawa, K | 1 |
| Matsuo, H | 1 |
| Omae, T | 1 |
1 review available for nicardipine and Malignant Hypertension
| Article | Year |
|---|---|
Thrombotic thrombocytopenic purpura: the masquerader.
Topics: Acute Kidney Injury; ADAM Proteins; ADAMTS13 Protein; Adult; Diagnosis, Differential; Erythrocytes, | 2009 |
2 other studies available for nicardipine and Malignant Hypertension
| Article | Year |
|---|---|
Nicardipine is a safe and effective agent in pediatric hypertensive emergencies.
Topics: Adolescent; Calcium Channel Blockers; Child; Female; Heart Failure; Humans; Hypertension, Malignant; | 2000 |
Antihypertensive therapy reduces increased plasma levels of adrenomedullin and brain natriuretic peptide concomitant with regression of left ventricular hypertrophy in a patient with malignant hypertension.
Topics: Adrenomedullin; Antihypertensive Agents; Atrial Fibrillation; Blood Pressure; Echocardiography; Elec | 1996 |